An aspergillosis that is a serious fungal infection of the lung with pneumonia caused by Aspergillus, which spreads to other parts of the body through bloodstream in patients with acute leukemia and r...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The limited documentation surrounding invasive aspergillosis stems from its classification as a rare and complex fungal infection, primarily affecting a small subset of immunocompromised individuals. Systematic clinical studies are scarce, as the condition is often overshadowed by more common infections. Additionally, the lack of identified genetic factors and phenotypic characterization contributes to the challenge in gathering comprehensive clinical data.
To navigate your care for invasive aspergillosis, consider seeking a specialist in infectious diseases with experience in fungal infections. These experts can provide tailored management strategies. Additionally, you may want to explore clinical trial opportunities to access cutting-edge treatments. Resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide further information and support. While there are currently no patient organizations identified, connecting with healthcare providers specializing in rare diseases can also be beneficial.
There are several orphan drugs designated for the treatment of invasive aspergillosis, including isavuconazonium sulfate and posaconazole, which are FDA-approved. Other drugs in development include fosmanogepix, olorofim, and opelconazole. Currently, there are 20 active clinical trials investigating various aspects of this condition. For more information on these trials, you can visit ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=invasive%20aspergillosis.
Actionable guidance for navigating care for invasive aspergillosis
To navigate your care for invasive aspergillosis, consider seeking a specialist in infectious diseases with experience in fungal infections. These experts can provide tailored management strategies. Additionally, you may want to explore clinical trial opportunities to access cutting-edge treatments. Resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide further information and support. While there are currently no patient organizations identified, connecting with healthcare providers specializing in rare diseases can also be beneficial.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 7 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.